142 related articles for article (PubMed ID: 38456333)
1. Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota.
Li H; Dong T; Tao M; Zhao H; Lan T; Yan S; Gong X; Hou Q; Ma X; Song Y
Food Funct; 2024 Apr; 15(7):3463-3478. PubMed ID: 38456333
[TBL] [Abstract][Full Text] [Related]
2. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy.
Huang J; Liu D; Wang Y; Liu L; Li J; Yuan J; Jiang Z; Jiang Z; Hsiao WW; Liu H; Khan I; Xie Y; Wu J; Xie Y; Zhang Y; Fu Y; Liao J; Wang W; Lai H; Shi A; Cai J; Luo L; Li R; Yao X; Fan X; Wu Q; Liu Z; Yan P; Lu J; Yang M; Wang L; Cao Y; Wei H; Leung EL
Gut; 2022 Apr; 71(4):734-745. PubMed ID: 34006584
[TBL] [Abstract][Full Text] [Related]
3. Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer.
Zhang SL; Mao YQ; Zhang ZY; Li ZM; Kong CY; Chen HL; Cai PR; Han B; Ye T; Wang LS
Theranostics; 2021; 11(9):4155-4170. PubMed ID: 33754054
[No Abstract] [Full Text] [Related]
4. Dietary fucoidan modulates the gut microbiota in mice by increasing the abundance of Lactobacillus and Ruminococcaceae.
Shang Q; Shan X; Cai C; Hao J; Li G; Yu G
Food Funct; 2016 Jul; 7(7):3224-32. PubMed ID: 27334000
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive Probiotic
Gao G; Ma T; Zhang T; Jin H; Li Y; Kwok LY; Zhang H; Sun Z
Front Immunol; 2021; 12():772532. PubMed ID: 34970262
[TBL] [Abstract][Full Text] [Related]
6. Metformin facilitates anti-PD-L1 efficacy through the regulation of intestinal microbiota.
Zhao X; Liu C; Peng L; Wang H
Genes Immun; 2024 Feb; 25(1):7-13. PubMed ID: 38092885
[TBL] [Abstract][Full Text] [Related]
7. Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota.
Deng Z; Wu N; Wang J; Geng L; Yue Y; Wang F; Zhang Q
Int J Biol Macromol; 2021 Dec; 193(Pt A):789-798. PubMed ID: 34743939
[TBL] [Abstract][Full Text] [Related]
8. Anti-obesity effects of
Zhang X; You Y; Wang L; Ai C; Huang L; Wang S; Wang Z; Song S; Zhu B
Food Funct; 2022 Jun; 13(11):6259-6270. PubMed ID: 35593392
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan Protects Against High-Fat Diet-Induced Obesity and Modulates Gut Microbiota in Institute of Cancer Research Mice.
Huang J; Huang J; Li Y; Lv H; Yin T; Fan S; Zhang C; Li H
J Med Food; 2021 Oct; 24(10):1058-1067. PubMed ID: 34668763
[TBL] [Abstract][Full Text] [Related]
10. [Association between Immunotherapy with Immune Checkpoint Inhibitors(Anti-PD-1 Antibodies)and Intestinal Microbiota].
Ozaki Y; Suzuki Y; Nishiyama K; Suzutani T; Suzuki H
Gan To Kagaku Ryoho; 2021 Sep; 48(9):1096-1099. PubMed ID: 34521783
[TBL] [Abstract][Full Text] [Related]
11. The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer.
Peng Z; Cheng S; Kou Y; Wang Z; Jin R; Hu H; Zhang X; Gong JF; Li J; Lu M; Wang X; Zhou J; Lu Z; Zhang Q; Tzeng DTW; Bi D; Tan Y; Shen L
Cancer Immunol Res; 2020 Oct; 8(10):1251-1261. PubMed ID: 32855157
[TBL] [Abstract][Full Text] [Related]
12. Fucoidan Ameliorated Dextran Sulfate Sodium-Induced Ulcerative Colitis by Modulating Gut Microbiota and Bile Acid Metabolism.
Liu X; Zhang Y; Li W; Zhang B; Yin J; Liuqi S; Wang J; Peng B; Wang S
J Agric Food Chem; 2022 Nov; 70(47):14864-14876. PubMed ID: 36378195
[TBL] [Abstract][Full Text] [Related]
13.
Zhang SL; Han B; Mao YQ; Zhang ZY; Li ZM; Kong CY; Wu Y; Chen GQ; Wang LS
Gut Microbes; 2022; 14(1):2046246. PubMed ID: 35259052
[TBL] [Abstract][Full Text] [Related]
14. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.
Dong M; Meng Z; Kuerban K; Qi F; Liu J; Wei Y; Wang Q; Jiang S; Feng M; Ye L
Cell Death Dis; 2018 Oct; 9(10):1039. PubMed ID: 30305604
[TBL] [Abstract][Full Text] [Related]
15. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
16. [The Gut Microbiota Metabolite A Enhances the Anti-Tumor Effects of Anti-PD-1 Antibody Therapy through Immune Modulation].
Hosonuma M; Murayama M; Yoshimura K
Gan To Kagaku Ryoho; 2023 Sep; 50(9):960-964. PubMed ID: 37800288
[TBL] [Abstract][Full Text] [Related]
17.
Zhao J; Wang Y; Wang J; Lv M; Zhou C; Jia L; Geng W
Food Funct; 2022 Oct; 13(19):10023-10033. PubMed ID: 36069328
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan isolated from Ascophyllum nodosum alleviates gut microbiota dysbiosis and colonic inflammation in antibiotic-treated mice.
Wang L; Ai C; Wen C; Qin Y; Liu Z; Wang L; Gong Y; Su C; Wang Z; Song S
Food Funct; 2020 Jun; 11(6):5595-5606. PubMed ID: 32525182
[TBL] [Abstract][Full Text] [Related]
19. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
